@richardfuisz @Jess_Riedel @ESYudkowsky Note that the article I linked to talked about type 2 diabetes, but after searching a bit, it appears like this assessment of the safety risks may also be true for type 1 diabetes. https://t.co/knAxfOQTlh https://t.c
Short acting insulin analogues act more quickly than regular human insulin, increasing the life quality of people with Type 1 Diabetes, but regular human insulin can in long term glycaemic control be nearly as effective. https://t.co/7xDtdnK3ja
@ElizabethType1 @Jandelliott @MsAllisonBailey Short acting insulin analogues act more quickly than regular human insulin, but regular human insulin can in long term glycaemic control be nearly as effective. https://t.co/7xDtdnK3ja